Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

Author： Harrison Simon J.   Hsu Andy K.   Neeson Paul   Younes Anas   Sureda Anna   Engert Andreas   Prince H. Miles   Li Martha   Savage Paula   Bugarini Roberto   Williams Denise   Squier Margaret   Ritchie David S.  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.5, 2014-05, pp. : 1053-1060

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease - a prospective randomised trial

By van Agthoven M.   Vellenga E.   Fibbe W.E.   Kingma T.   Uyl-de Groot C.A.  

European Journal of Cancer, Vol. 37, Iss. 14, 2001-09 ,pp. : 1781-1789

Elsevier

Access to resources Recommend Favorite

Treatment related myelitis in hodgkin’s lymphoma following stem cell transplant, chemotherapy and radiation: a case report and review of the literature

By Gatcombe Heather   Lawson Josh   Phuphanich Surasak   Crocker Ian  

Journal of Neuro-Oncology, Vol. 79, Iss. 3, 2006-09 ,pp. : 293-298

Springer Publishing Company

Access to resources Recommend Favorite

Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma

By          

Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. : 1203-1206

Spandidos Publications

Access to resources Recommend Favorite

Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

By Mey Ulrich   Orlopp Katjana   Flieger Dimitri   Strehl John   Ho Anthony   Hensel Manfred   Bopp Cordula   Gorschlüter Marcus   Wilhelm Martin   Birkmann Josef   Kaiser Ulrich   Neubauer Andreas   Florschütz Axel   Rabe Christian   Hahn Corinna   Glasmacher Axel   Schmidt-Wolf Ingo  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies

By Zaja Francesco   Federico Massimo   Vitolo Umberto   Zinzani Pier Luigi  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 988-998

Informa Healthcare

Access to resources Recommend Favorite